Dilan Patel

Medicine & Life Sciences

1. Sickle Cell Anemia 100%
2. Transplants 69%
3. Cyclophosphamide 62%
4. Multiple Myeloma 60%
5. elotuzumab 54%
6. Lenalidomide 54%
7. Lymphoma 50%
8. Bone Marrow 48%
9. Bortezomib 48%
10. Rituximab 46%
11. pazopanib 45%
12. Nelfinavir 45%
13. Survival 45%
14. Facial Injuries 44%
15. Matrix Metalloproteinase 7 44%
16. Tooth Injuries 43%
17. Lymphoma, Large B-Cell, Diffuse 41%
18. Immune Reconstitution 40%
19. Ambulatory Monitoring 40%
20. Kidney Pelvis 37%
21. Residual Neoplasm 37%
22. Spinal Cord Compression 37%
23. Triple Negative Breast Neoplasms 36%
24. Proteasome Inhibitors 36%
25. Football 35%
26. T-Lymphocytes 33%
27. Dexamethasone 32%
28. Hematopoietic Stem Cell Transplantation 32%
29. Craniocerebral Trauma 30%
30. Helicobacter pylori 29%
31. High-Throughput Nucleotide Sequencing 29%
32. Computer Simulation 28%
33. Hepacivirus 28%
34. Lymphocyte Count 24%
35. Chimeric Antigen Receptors 24%
36. Therapeutics 24%
37. Neutrophils 23%
38. Virus Diseases 22%
39. Lymphocytes 21%
40. Tissue Donors 20%
41. Carcinoma 20%
42. Whole-Body Irradiation 17%
43. Wounds and Injuries 17%
44. Mutation 17%
45. Drug Therapy 17%
46. Siblings 13%
47. Neoplasms 13%
48. Gastritis 13%
49. Stomach 13%